Navigation Links
RoosterBio Launches the Only Umbilical Cord hMSC System in the World Designed for Cell Therapy Product Development
Date:9/8/2019

RoosterBio, Inc, a biotechnology market disrupter and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announces its release of the Regenerative Medicine industry’s first human umbilical cord (hUC) MSC paired cell and media system designed for product development. RoosterBio continues to simplify MSC production by introducing an unprecedented step-change in quantifiable productivity metrics. RoosterVial™-hUC-MSC-XF, allows scientists to generate billions of perinatal cells in a fraction of the time when paired with RoosterBio’s existing xeno-free hMSC plug and play systems. This product line is the only commercially available, high-volume perinatal MSC bioprocess system with a line of sight to towards clinical translation.

“Until now, there was not a hUC-MSC on the market that would support the quality and scale needs of cell therapy product developers,” said RoosterBio Founder & Chief Product Officer Jon A. Rowley, PhD. RoosterBio’s launch of RoosterVial-hUC-MSC-XF introduces another first-in-class hMSC product on the market that simplifies all aspects of product development. “This very powerful set of biological tools has now been released into the Regenerative Medicine marketplace, introducing a major step-change in MSC productivity,” added Dr. Rowley.

The adoption of umbilical cord hMSC product development in Asia and Europe has demonstrated hUC-MSCs are the fastest growing tissue type and second in overall usage within hMSC Regenerative Medicine applications, according to recent global research publications. hUC-MSC product development in North America has been slower to develop due to the lack of availability of this critical raw material.

RoosterBio’s xeno-free hUC-MSCs are isolated from the perivascular Wharton’s Jelly region of the human umbilical cord and is collected after birth. “RoosterBio’s first-in-class characterization of hUC-MSC key quality attributes along with our readily implementable process recommendations gives added confidence in quality, reproducibility, and ease of integration,” said Dr. Rowley. “By introducing new tissue types, we are opening the door to support the incorporation of these new living cellular technologies into product development across the globe.”

Along with RoosterBio’s paired bioprocess media system, RoosterVial-hUC reaches new levels in hMSC expansion in terms of M cells/L media consumed as well as extracellular vesicle (EV) productivity. The product is backed by licensed intellectual property (IP) from Tissue Regeneration Therapeutics (TRT), a Canadian Controlled Private Corporation with a focus on Human Umbilical Cord PeriVascular Cell (HUCPVC) technology.

RoosterBio announced the collaboration with Tissue Regeneration Therapeutics in May 2019 which gave RoosterBio an exclusive worldwide license to TRT’s patent estate related to the manufacture and global sale of human umbilical cord-derived MSCs. The announcement advances both companies shared goal of accelerating the development of the Regenerative Medicine industry.

Visit https://www.roosterbio.com/collections/high-volume-hmscs for more information about RoosterBio’s radically simplified xeno-free hUC-MSCs.

About RoosterBio, Inc
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio's products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit http://www.roosterbio.com.

Read the full story at https://www.prweb.com/releases/roosterbio_launches_the_only_umbilical_cord_hmsc_system_in_the_world_designed_for_cell_therapy_product_development/prweb16551515.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. RoosterBio Will Attend Society for Biomaterials Annual Meeting April 3-6, 2019
2. RoosterBio Announces Plans to Expand Facility in Frederick, MD
3. RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
4. RoosterBio, Inc. Earns NIIMBL Nod with 2 Grant Awards for Regenerative Medicine Manufacturing
5. BioInformatics Launches New Experts-on-Demand Qualitative Research Service
6. Deep Science Ventures Launches Europe’s First Venture-Building Programme for Food & Agriculture
7. ActX Launches a Genetic Medical Interpretation Service for 23andMe Customers
8. FileWave Launches Version 13.1
9. ASGCT Launches Clinical Trials Finder on Clinical Trials Day 2019
10. Akadeum Launches Seven New Products at Immunology 2019 Conference in San Diego
11. FISO Technologies Launches the FOP-M200, the Smallest Commercially Available Pressure Transducer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2020)... ... May 14, 2020 , ... The annual salary ... found the 2019 average medical sales rep total compensation increased by $12,000 over ... amid the COVID-19 global crisis. , The MedReps 2020 Salary Survey revealed yet ...
(Date:5/1/2020)... , ... April 30, 2020 , ... ... backed by Siemens Healthineers and several healthcare VC firms announces an official launch ... of CareDoctors.com is to enhance patient care experience by offering live video consultations ...
(Date:4/30/2020)... (PRWEB) , ... April 28, 2020 , ... Pebble ... world’s biggest challenges in agriculture and aquaculture with the mission of improving global food ... the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ' virtual event, ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... ... 06, 2020 , ... Gateway Genomics , leading developer of direct-to-consumer genetic ... Gender DNA Tests sold in March, just months after attaining the 150,000-test landmark ... where a mom could order her kit online, collect a DNA sample from her ...
(Date:4/1/2020)... ... March 30, 2020 , ... ... product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology within ... provides continual antimicrobial activity against microorganisms for up to 90 days. , In ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... using its revolutionary NEXTGENPCR endpoint thermocycler and consumables that decreases PCR amplification ... samples per run, and standard, affordable laboratory equipment, a qualitative protocol was ...
(Date:4/1/2020)... ... March 31, 2020 , ... ... the signing of a Joint Development Agreement that builds on each company’s expertise ... a global leader in the supply of high-quality insect pheromones as well as ...
Breaking Biology Technology: